Related Experiment Video
Updated: May 21, 2025

A Preterm Rat Model for Pain Studies
Published on: February 9, 2024
Association between early-phase opioid use and outcomes in extremely preterm infants: A nationwide study
Hiroki Kitaoka1,2, Takaaki Konishi3, Yoshihiko Shitara4
1Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan. kitaokahir@m.u-tokyo.ac.jp.
Insights
Early opioid use in extremely preterm infants did not increase mortality or intraventricular hemorrhage. While periventricular leukomalacia decreased, longer hospital stays and increased bronchopulmonary dysplasia were observed.
Area of Science:
- Neonatalogy
- Pharmacology
- Pediatric Critical Care
Background:
- Opioids are frequently used for extremely preterm infants to prevent serious conditions like intraventricular hemorrhage.
- The short-term effects of early opioid administration on infant outcomes are not well-understood.
- This study investigates the association between early opioid use and in-hospital outcomes in this vulnerable population.
Purpose of the Study:
- To assess the association between early-phase opioid administration and in-hospital outcomes in extremely preterm infants.
- To determine if early opioid use impacts mortality, major morbidities, or healthcare resource utilization.
- To provide evidence for clinical decision-making regarding opioid use in neonatal intensive care.
Main Methods:
- A retrospective nationwide cohort study utilizing Japan's Diagnosis Procedure Combination database.
- Inclusion of 18,794 extremely preterm infants hospitalized between July 2010 and March 2021.
- A 1:2 propensity score-matched analysis comparing infants who received early opioids (n=4806) versus those who did not (n=13,988).
Main Results:
- In-hospital mortality and intraventricular hemorrhage rates were similar between opioid-exposed and non-exposed groups post-matching.
- A statistically significant decrease in periventricular leukomalacia was observed in infants receiving early opioids (1.7% vs. 2.2%).
- However, early opioid use was associated with increased rates of bronchopulmonary dysplasia (65% vs. 58%), higher home assistive technology use (19% vs. 15%), and longer hospital stays (125 vs. 122 days).
Conclusions:
- Early-phase opioid administration in extremely preterm infants is not linked to increased in-hospital mortality or intraventricular hemorrhage.
- A slight reduction in periventricular leukomalacia was noted with early opioid use.
- Despite these benefits, clinicians should consider the increased risks of bronchopulmonary dysplasia and prolonged hospitalization associated with early opioid exposure.
Background:
Opioids are often administered for extremely preterm infants to prevent morbidities (e.g., intraventricular hemorrhage); however, their short-term outcome remains unclear. We aimed to assess the association between early-phase opioid use and in-hospital outcomes in extremely preterm infants.
Methods:
This retrospective nationwide cohort study analyzed data from the Diagnosis Procedure Combination database in Japan. A total of 18,794 extremely preterm infants hospitalized between July 2010 and March 2021 were included. The patients were divided into those who received early-phase opioids (n = 4806) and those who did not (n = 13,988). We performed a 1:2 propensity score-matched analysis adjusting for patient backgrounds.
Results:
In-hospital mortality, intraventricular hemorrhage, and periventricular leukomalacia occurred in 8.5%, 13%, and 2.1% of the patients, respectively. The incidences of in-hospital mortality (12% vs. 12%) and intraventricular hemorrhage (14% vs. 15%) did not differ between the two groups after 1:2 propensity score matching. The patients who received early-phase opioids had a lower incidence of periventricular leukomalacia than those who did not (1.7% vs. 2.2%). However, bronchopulmonary dysplasia occurrence (65% vs. 58%), home assistive technology use (19% vs. 15%), and length of hospital stay (125 vs. 122 days) were increased for patients who received early-phase opioids.
Conclusion:
In this large retrospective study, early-phase opioid use in extremely preterm infants was not associated with increased mortality or intraventricular hemorrhage. Periventricular leukomalacia slightly decreased.
Impact:
This large retrospective nationwide study of 13,988 extremely preterm infants revealed that using early-phase opioids was not significantly associated with in-hospital mortality or intraventricular hemorrhage but was significantly associated with a decrease in periventricular leukomalacia. Early-phase opioids may not increase mortality or intraventricular hemorrhage, in contrast to the results of previous studies. Thus, these results could help clinicians select opioids as sedative agents for extremely preterm infants.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Opioid Receptors: Overview
Factors Affecting Drug Response: Overview
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

